{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ACE2",
      "Covid-19",
      "SARS-CoV-2",
      "TMPRSS2",
      "entry molecule"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33368788",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e2207",
      "10.1002/rmv.2207"
    ],
    "Journal": {
      "ISSN": "1099-1654",
      "JournalIssue": {
        "Volume": "31",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "Reviews in medical virology",
      "ISOAbbreviation": "Rev Med Virol"
    },
    "ArticleTitle": "Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "9",
      "MedlinePgn": "1-9"
    },
    "Abstract": {
      "AbstractText": [
        "Understanding the molecules that are essential for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) entry can provide insights into viral infection and dissemination. Recently, it has been identified from several studies that angiotensin-converting enzyme 2 receptor and transmembrane serine protease 2 are the main entry molecules for the SARS-CoV-2, which produced the pandemic of Covid-19. However, additional evidence showed several other viral receptors and cellular proteases that are also important in facilitating viral entry and transmission in the target cells. In this review, we summarized the types of SARS-CoV-2 entry molecules and discussed their crucial roles for virus binding, protein priming and fusion to the cellular membrane important for SARS-CoV-2 infection."
      ],
      "CopyrightInformation": "\u00a9 2020 John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-4202-2289"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Health Sciences, Centre for Toxicology and Health Risk Studies, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Masre",
        "ForeName": "Siti Fathiah",
        "Initials": "SF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Health Sciences, Centre for Toxicology and Health Risk Studies, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Jufri",
        "ForeName": "Nurul Farhana",
        "Initials": "NF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Health Sciences, Centre for Toxicology and Health Risk Studies, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Ibrahim",
        "ForeName": "Farah Wahida",
        "Initials": "FW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pantai Premier Pathology SDN BHD, Reference Specialised Laboratory, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia."
          }
        ],
        "LastName": "Abdul Raub",
        "ForeName": "Sayyidi Hamzi",
        "Initials": "SH"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Rev Med Virol",
    "NlmUniqueID": "9112448",
    "ISSNLinking": "1052-9276"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Virus"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Receptors, Virus"
    },
    {
      "QualifierName": [
        "genetics",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare that there is no conflict of interest."
}